VHH Fragment Antibodies

High-purity antibodies for immunoassays, Western blotting, flow cytometry, and immunohistochemistry applications.

Purified monoclonal antibodies with high binding affinity and specificity, isolated from terminal differentiated plasma cells. Suitable for sensitive detection and diagnostic applications.

Recombinant rabbit monoclonal antibodies for use in diagnostic and research applications. These antibodies enable specific target detection in immunoassays, flow cytometry, and immunohistochemistry protocols. Produced through recombinant DNA technology, they offer consistency, reproducibility, and reduced batch variability compared to traditional hybridoma methods.

Validated immunohistochemistry antibodies and reagents for precise protein visualization in tissue samples, supporting disease research and diagnostic applications.

Recombinant antibodies for diagnostic and research applications, produced through mammalian cell culture and protein expression systems. These engineered proteins serve as critical reagents in immunoassay development, antigen detection, and therapeutic target identification. Suitable for integration into diagnostic kits, clinical assays, and preclinical research workflows.

Low cross-reactivity antibodies specifically designed for in vitro diagnostic immunoassays, enabling accurate disease detection, therapeutic monitoring, and drug screening.

IHC/IF antibodies and ISH probes for immunohistochemistry, immunofluorescence, and in situ hybridization applications in pathological anatomy. These reagents enable visualization and identification of specific antigens and nucleic acid targets in tissue samples for diagnostic and research purposes.

Monoclonal antibodies including murine whole antibodies obtained in ascitic fluid or in vitro culture, as well as recombinant mouse and chimeric humanized antibodies produced in the HEK293 cell line. These reagents are intended as key components for diagnostic test production.

Absorbed secondary polyclonal antibodies optimized to minimize species cross-reactivity and conjugated for enhanced assay-specific performance in research and diagnostics.

Antibodies targeting inflammatory biomarkers IFN-γ, IL-6, and HBP for development of inflammatory marker immunoassays.

IHC primary antibodies for immunohistochemical detection and visualization of specific antigens in tissue samples. These reagents enable pathologists and researchers to identify disease markers, classify tumors, and support diagnostic decision-making in anatomical pathology and research applications.